Matthew R. Kwietniak Avid Bioservices, Inc. (CDMO) insider trading activity

Matthew R. Kwietniak is Chief Commercial Officer of Avid Bioservices, Inc.. Currently has a direct ownership of 23,410 shares of CDMO, which is worth approximately $267,342. The most recent transaction as insider was on Jul 15, 2024, when has been sold 307 shares (Common Stock, $0.001 par value) at a price of $8.36 per share, resulting in proceeds of $2,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K

7.4% 3M change

46.46% 12M change

Total Value Held $267,342

Matthew R. Kwietniak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2024	SELL Open market or private sale	$2,566 $8.36 p/Share	307 Reduced 1.29%	23,410 Common Stock, $0.001 p...
Jul 12 2024	SELL Open market or private sale	$957 $8.05 p/Share	119 Reduced 0.52%	22,836 Common Stock, $0.001 p...
Jul 12 2024	BUY Exercise of conversion of derivative security	-	881 Added 3.58%	23,717 Common Stock, $0.001 p...
Jul 11 2024	BUY Exercise of conversion of derivative security	-	335 Added 1.44%	22,955 Common Stock, $0.001 p...
Jul 10 2024	SELL Open market or private sale	$3,347 $7.54 p/Share	444 Reduced 1.93%	22,620 Common Stock, $0.001 p...
Jul 09 2024	BUY Exercise of conversion of derivative security	-	1,267 Added 5.21%	23,064 Common Stock, $0.001 p...
Apr 30 2024	SELL Open market or private sale	$9,124 $7.4 p/Share	1,233 Reduced 5.35%	21,797 Common Stock, $0.001 p...
Apr 11 2024	BUY Exercise of conversion of derivative security	-	669 Added 2.82%	23,030 Common Stock, $0.001 p...
Apr 09 2024	BUY Exercise of conversion of derivative security	-	2,532 Added 10.17%	22,361 Common Stock, $0.001 p...
Jan 12 2024	SELL Open market or private sale	$1,854 $6.77 p/Share	274 Reduced 1.36%	19,829 Common Stock, $0.001 p...
Jan 11 2024	BUY Exercise of conversion of derivative security	-	669 Added 3.22%	20,103 Common Stock, $0.001 p...
Jan 10 2024	SELL Open market or private sale	$6,540 $6.17 p/Share	1,060 Reduced 5.17%	19,434 Common Stock, $0.001 p...
Jan 09 2024	BUY Exercise of conversion of derivative security	-	2,533 Added 11.0%	20,494 Common Stock, $0.001 p...
Oct 12 2023	SELL Open market or private sale	$2,343 $9.19 p/Share	255 Reduced 1.4%	17,961 Common Stock, $0.001 p...
Oct 11 2023	BUY Exercise of conversion of derivative security	-	670 Added 3.55%	18,216 Common Stock, $0.001 p...
Oct 10 2023	SELL Open market or private sale	$8,924 $9.2 p/Share	970 Reduced 5.24%	17,546 Common Stock, $0.001 p...
Oct 09 2023	BUY Exercise of conversion of derivative security	-	2,532 Added 12.03%	18,516 Common Stock, $0.001 p...
Jul 12 2023	SELL Open market or private sale	$3,429 $13.61 p/Share	252 Reduced 1.55%	15,984 Common Stock, $0.001 p...
Jul 11 2023	BUY Exercise of conversion of derivative security	-	669 Added 3.96%	16,236 Common Stock, $0.001 p...
Jul 10 2023	SELL Open market or private sale	$6,568 $13.77 p/Share	477 Reduced 2.97%	15,567 Common Stock, $0.001 p...
Jul 09 2023	BUY Exercise of conversion of derivative security	-	1,261 Added 7.29%	16,044 Common Stock, $0.001 p...
Jun 30 2023	BUY Other acquisition or disposition	$8,205 $11.46 p/Share	716 Added 4.62%	14,783 Common Stock, $0.001 p...
Jun 29 2023	SELL Open market or private sale	$50,126 $12.7 p/Share	3,947 Reduced 21.91%	14,067 Common Stock, $0.001 p...
Jun 28 2023	BUY Exercise of conversion of derivative security	-	10,365 Added 36.52%	18,014 Common Stock, $0.001 p...

MRK

Matthew R. Kwietniak

Chief Commercial Officer

Tustin, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDMO shares.

Notify only if

Value

Insider Trading

Get notified when an Avid Bioservices, Inc. insider buys or sells CDMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Avid Bioservices, Inc.

Track Activities on CDMO

Account